PrimeRFP SCOUT · Federal Contract Recompete Brief

FA238423FB001Biotechnology for HUMAN HEALTH and performance — Ues, Inc

Ues, Inc holds $230.0M across 86 federal awards, concentrated at Department of Defense (DOD). This PIID sits alongside 5 related awards under parent FA865019D6109. Recompete timing centers on the Aug 26, 2027 PoP end — agencies typically plan 12–18 months ahead.

Fa2384 Usaf Afmc Afrl Pzl Afrl Rakh

Awarding office

Ues, Inc

Recipient

Aug 26, 2027

PoP end

$15M

Obligated

$15M

Potential

541715

NAICS

AC12

PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Ues, Inc — $90

Contract facts

Federal

Contract numberFA238423FB001

Also listed asFA865019D6109-FA238423FB001

AgencyFa2384 Usaf Afmc Afrl Pzl Afrl Rakh

Awarding officeFa2384 Usaf Afmc Afrl Pzl Afrl Rakh

Awarding agencyDepartment of Defense (DOD)

Funding agencyDepartment of Defense (DOD)

IncumbentUes, Inc

CAGE7H233

UEIFV5WK6YTN215

NAICS541715

PSCAC12

Parent IDIQ / IDVFA865019D6109

Place of performanceBEAVERCREEK OH

Pricing typeCost Plus Fixed Fee

Extent competedFull And Open Competition

PoP startSep 20, 2023

PoP end (current)Aug 26, 2027

Obligated$15M

Current value$15M

Potential value$15M

BIOTECHNOLOGY FOR HUMAN HEALTH AND PERFORMANCE is a federal award for Fa2384 Usaf Afmc Afrl Pzl Afrl Rakh held by Ues, Inc. Estimated value $15M ($15M obligated). Current period of performance ends Aug 26, 2027. Place of performance: BEAVERCREEK OH.

BIOTECHNOLOGY FOR HUMAN HEALTH AND PERFORMANCE

Recompete timing

Public

● Expiring in 370 days

Current PoP ends Aug 26, 2027 (370 days remaining). Agencies typically plan 12–18 months ahead — position before the PoP clock runs out.

Incumbent footprint

Public record

Ues, Inc — $230.0M obligated across 86 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).

% of firm-wide obligated ($230.0M) · all agencies

Department of Defense (DOD)$230.0M · 100%National Aeronautics and Space Administration (NASA)$15K · 0%

Open full company profile →

Related awards

Same parent · incumbent

FA865022F5401

BIOTECHNOLOGY AND BIOMATERIALS R&D AND EXPLORATION

$29.7M

Sep 15, 2026

FA865021F5238

PICASSO ROSE - INCREMENTAL FUNDING

$6.0M

Jan 31, 2027

FA239124CB027

HIGH VOLTAGE AIRCRAFT POWER SYSTEM (HVAPS)

$6.0M

Jun 4, 2027

FA865023F6444

OPERATIONAL SENSING AND PERFORMANCE MONITORING - NEW TASK ORDER

$10.0M

Jun 6, 2027

FA865019F2906

POWER ENERGY THERMAL INTEGRATION AND CONTROLS

$33.0M

Jun 11, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract FA238423FB001?

FA238423FB001 (Biotechnology for HUMAN HEALTH and performance) is a Fa2384 Usaf Afmc Afrl Pzl Afrl Rakh award with a potential value of $15M, currently held by Ues, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded FA238423FB001?

Fa2384 Usaf Afmc Afrl Pzl Afrl Rakh awarded FA238423FB001 to Ues, Inc (potential $15M).

Who is the incumbent on FA238423FB001?

Ues, Inc is the incumbent with $230.0M across 86 related awards in SCOUT’s public footprint. The current period of performance ends Aug 26, 2027.

When does Ues, Inc’s FA238423FB001 come up for recompete?

SCOUT tracks a period-of-performance end of Aug 26, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 19, 2026 · refreshed monthlyLatest procurement action Feb 12, 2026